AR019485A1 - Una composicion farmaceutica y el metodo para producir y administrar la misma. - Google Patents

Una composicion farmaceutica y el metodo para producir y administrar la misma.

Info

Publication number
AR019485A1
AR019485A1 ARP990103691A ARP990103691A AR019485A1 AR 019485 A1 AR019485 A1 AR 019485A1 AR P990103691 A ARP990103691 A AR P990103691A AR P990103691 A ARP990103691 A AR P990103691A AR 019485 A1 AR019485 A1 AR 019485A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
drug
manage
produce
same
Prior art date
Application number
ARP990103691A
Other languages
English (en)
Spanish (es)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR019485A1 publication Critical patent/AR019485A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ARP990103691A 1998-07-31 1999-07-27 Una composicion farmaceutica y el metodo para producir y administrar la misma. AR019485A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21751798 1998-07-31

Publications (1)

Publication Number Publication Date
AR019485A1 true AR019485A1 (es) 2002-02-20

Family

ID=16705487

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103691A AR019485A1 (es) 1998-07-31 1999-07-27 Una composicion farmaceutica y el metodo para producir y administrar la misma.

Country Status (10)

Country Link
EP (1) EP1100466A1 (de)
KR (1) KR20010072151A (de)
CN (1) CN1161106C (de)
AR (1) AR019485A1 (de)
AU (1) AU4802699A (de)
BR (1) BR9912533A (de)
CA (1) CA2338996A1 (de)
HK (1) HK1040191A1 (de)
ID (1) ID28910A (de)
WO (1) WO2000006122A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004535370A (ja) 2001-03-05 2004-11-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 味をマスクした液体製薬学的組成物
CA2440069A1 (en) 2001-03-05 2002-09-12 Ortho-Mcneil Pharmaceutical, Inc. Taste masked pharmaceutical compositions
US20070053981A1 (en) * 2003-07-11 2007-03-08 Eva Blychert Solid composition comprising a proton pump inhibitor
CN100435847C (zh) * 2004-05-13 2008-11-26 宝龄富锦生技股份有限公司 含有难溶解性主药之持续释放配方
CN1964699B (zh) 2004-06-07 2010-12-08 株式会社吴羽 干燥形态经口摄取用组合物和用时调制型凝胶状经口摄取用组合物
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
AU2011258600B2 (en) * 2010-05-24 2014-11-13 Amerilab Technologies, Inc. Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition
US9603805B2 (en) 2011-09-30 2017-03-28 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
SG10202109130WA (en) * 2017-02-21 2021-09-29 Ea Pharma Co Ltd Granular preparation
FR3101546B1 (fr) 2019-10-07 2023-11-10 Roquette Freres Masquage du goût de l’isosorbide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
GB9224855D0 (en) * 1992-11-27 1993-01-13 Smithkline Beecham Plc Pharmaceutical compositions
ATE352289T1 (de) * 1995-05-02 2007-02-15 Taisho Pharmaceutical Co Ltd Mittel zur oralen verabreichung
WO1997003656A1 (fr) * 1995-07-21 1997-02-06 Daiichi Pharmaceutical Co., Ltd. Preparation granulaire et son procede de production
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives

Also Published As

Publication number Publication date
CN1316899A (zh) 2001-10-10
WO2000006122A1 (en) 2000-02-10
AU4802699A (en) 2000-02-21
EP1100466A1 (de) 2001-05-23
BR9912533A (pt) 2002-02-13
ID28910A (id) 2001-07-12
CN1161106C (zh) 2004-08-11
HK1040191A1 (zh) 2002-05-31
KR20010072151A (ko) 2001-07-31
CA2338996A1 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
PA8509001A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR019485A1 (es) Una composicion farmaceutica y el metodo para producir y administrar la misma.
ES2411179T3 (es) Oblea de buprenorfina para la terapia de sustitución de drogas
AR054139A1 (es) Formulacion modificada y de liberacion inmediata de esferas de memantina
EA200600484A1 (ru) Доставка физиологических агентов in situ при помощи гелей, включающих анионные полисахариды
CO6470871A2 (es) Dosis de película oral rápidamente soluble, que contiene esteviósidos, como un agente enmascarante de un sabor desagradable.
AR033548A1 (es) Composicion farmaceutica que comprende un inhibidor de lipasa, un procedimiento para su preparacion, equipo transportable a modo de ''kit'', el uso de dicha composicion en la fabricacion de medicamentos, un inhibidor de lipasa y un secuestrante de acidos biliares
WO2005065646A3 (en) Novel drug compositions and dosage forms
UY24246A1 (es) Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
TWI265809B (en) Dispersible pharmaceutical composition for treatment of mastitis and otic disorders
CL2004000573A1 (es) Composicion farmaceutica que comprende un aceite anfipatico, cera microcristalina y un vehiculo no acuoso, donde dicho vehiculo tiene disperso un agente antiinflamatorio, y su uso para tratar y/o prevenir una afeccion inflamatoria en un organo que co
DE60220408D1 (de) Sequenzielles arzneimittelabgabesystem
DE602004026604D1 (de) Pharmazeutische kombinationen von hydrocodon und naltrexon
SG152257A1 (en) Topical preparation containing ambroxol
ATE419039T1 (de) Pharmazeutische kombinationen von oxycodon und naloxon
CO4970819A1 (es) Tratamiento de disfuncion sexual femenina en una hembra humana
BRPI0510259A (pt) formulação cosmética ou dermatológica transparente
RU2009120990A (ru) Применение тестостерона и агониста 5-нт1а для лечения сексуальной дисфункции
WO2005107810A3 (en) Pharmaceutical formulations and uses thereof in the treatment of female sexual dysfunction
ATE445389T1 (de) Liposomale glucocorticoide
HUP0000137A2 (hu) Szabályozott hatóanyag-felszabadulású analgetikumot tartalmazó gyógyszerkészítmény
WO2005065648A3 (en) Novel drug compositions and dosage forms of topiramate
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
IS6317A (is) Efni og lyf til að koma í veg fyrir endaþarms- og/eða ristilskrabbamein

Legal Events

Date Code Title Description
FA Abandonment or withdrawal